Literature DB >> 18508479

Proteomic identification of novel proteins associated with Lewy bodies.

Qiangwei Xia1, Lujian Liao, Dongmei Cheng, Duc M Duong, Marla Gearing, James J Lah, Allan I Levey, Junmin Peng.   

Abstract

The manifestation of Lewy bodies (LB) in the brain is a hallmark of Parkinson's disease. Here, we present a comprehensive analysis of protein elements in Lewy bodies by comparative mass spectrometry. Cortical LB inclusions were enriched by sucrose gradient centrifugation from postmortem brains, and a negative control sample was prepared from specimen without LB pathology. Whereas approximately 550 proteins were identified in the LB-enriched sample by mass spectrometry, quantitative comparison with the control sample revealed that approximately 40 proteins were co-enriched with alpha-synuclein, the major component in Lewy bodies. As expected, the list of proteins included previously reported constituents, such as those involved in protein folding, membrane trafficking and oxidative stress. More interestingly, we discovered in the LB-enriched sample several kinases (MAPKK1/MEK1, protein kinase C, and doublecortin-like kinase), a novel deubiquitinating enzyme (otubain 1), and numerous ubiquitin ligases (KPC and SCF). The proteomic studies provide enzyme candidates to investigate the regulation of alpha-synuclein and/or other LB proteins, which may contribute to the formation of Lewy bodies and the toxicity of alpha-synuclein in the related neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508479      PMCID: PMC2663966          DOI: 10.2741/2973

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  31 in total

Review 1.  Mass spectral analysis in proteomics.

Authors:  John R Yates
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

Review 2.  Ubiquitin and protein turnover in synapse function.

Authors:  Jason J Yi; Michael D Ehlers
Journal:  Neuron       Date:  2005-09-01       Impact factor: 17.173

3.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome.

Authors:  Junmin Peng; Joshua E Elias; Carson C Thoreen; Larry J Licklider; Steven P Gygi
Journal:  J Proteome Res       Date:  2003 Jan-Feb       Impact factor: 4.466

4.  Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Authors:  H Shimura; M G Schlossmacher; N Hattori; M P Frosch; A Trockenbacher; R Schneider; Y Mizuno; K S Kosik; D J Selkoe
Journal:  Science       Date:  2001-06-28       Impact factor: 47.728

Review 5.  Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome.

Authors:  Yair M Gozal; Dongmei Cheng; Duc M Duong; James J Lah; Allan I Levey; Junmin Peng
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

6.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

7.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.

Authors:  T G Mack; M Reiner; B Beirowski; W Mi; M Emanuelli; D Wagner; D Thomson; T Gillingwater; F Court; L Conforti; F S Fernando; A Tarlton; C Andressen; K Addicks; G Magni; R R Ribchester; V H Perry; M P Coleman
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

Review 8.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

9.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

Review 10.  Laser-capture microdissection: opening the microscopic frontier to molecular analysis.

Authors:  N L Simone; R F Bonner; J W Gillespie; M R Emmert-Buck; L A Liotta
Journal:  Trends Genet       Date:  1998-07       Impact factor: 11.639

View more
  70 in total

1.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.

Authors:  Bing Bai; Chadwick M Hales; Ping-Chung Chen; Yair Gozal; Eric B Dammer; Jason J Fritz; Xusheng Wang; Qiangwei Xia; Duc M Duong; Craig Street; Gloria Cantero; Dongmei Cheng; Drew R Jones; Zhiping Wu; Yuxin Li; Ian Diner; Craig J Heilman; Howard D Rees; Hao Wu; Li Lin; Keith E Szulwach; Marla Gearing; Elliott J Mufson; David A Bennett; Thomas J Montine; Nicholas T Seyfried; Thomas S Wingo; Yi E Sun; Peng Jin; John Hanfelt; Donna M Willcock; Allan Levey; James J Lah; Junmin Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-10       Impact factor: 11.205

2.  Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.

Authors:  Laura E Donovan; Lenora Higginbotham; Eric B Dammer; Marla Gearing; Howard D Rees; Qiangwei Xia; Duc M Duong; Nicholas T Seyfried; James J Lah; Allan I Levey
Journal:  Proteomics Clin Appl       Date:  2012-04       Impact factor: 3.494

3.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

4.  Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats.

Authors:  Fuminori Kawano; Yoshihiko Oke; Sachiko Nomura; Ryo Fujita; Takashi Ohira; Naoya Nakai; Yoshinobu Ohira
Journal:  J Physiol Sci       Date:  2011-08-03       Impact factor: 2.781

Review 5.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 6.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

Review 7.  Lysosomal impairment in Parkinson's disease.

Authors:  Benjamin Dehay; Marta Martinez-Vicente; Guy A Caldwell; Kim A Caldwell; Zhenyue Yue; Mark R Cookson; Christine Klein; Miquel Vila; Erwan Bezard
Journal:  Mov Disord       Date:  2013-04-11       Impact factor: 10.338

8.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

9.  OTUB1 attenuates neuronal apoptosis after intracerebral hemorrhage.

Authors:  Lili Xie; Aihong Li; Jiabing Shen; Maohong Cao; Xiaojin Ning; Debin Yuan; Yuteng Ji; Hongmei Wang; Kaifu Ke
Journal:  Mol Cell Biochem       Date:  2016-09-15       Impact factor: 3.396

10.  Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Authors:  Michael R Heaven; Daniel Flint; Shan M Randall; Alexander A Sosunov; Landon Wilson; Stephen Barnes; James E Goldman; David C Muddiman; Michael Brenner
Journal:  J Proteome Res       Date:  2016-06-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.